A Phase 1/2 First-in-Human Study of BMS-986249 Alone and in Combination with Nivolumab in Advanced Solid Tumors February 15, 2018 Type of Cancer Solid Tumor Sponsor Bristol Myers Squibb Protocol Number CA 090-001 To Learn More Call (201)-510-0950
